$IONI
I-ON Digital Corp.

2024 Q4 Form 10-Q Financial Statement

#000149315224044625 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $32.63K
YoY Change
Cost Of Revenue $14.33K
YoY Change
Gross Profit $18.30K
YoY Change
Gross Profit Margin 56.08%
Selling, General & Admin $344.3K $281.9K
YoY Change 188.93%
% of Gross Profit 1540.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $14.33K
YoY Change -100.0%
% of Gross Profit 78.31%
Operating Expenses $344.3K $281.9K
YoY Change 189.15%
Operating Profit -$344.3K -$263.6K
YoY Change 201.72%
Interest Expense -$160.6K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$131.1K -$90.59K
YoY Change
Pretax Income -$475.4K -$362.4K
YoY Change 316.65% 43.8%
Income Tax $830.00
% Of Pretax Income
Net Earnings -$475.4K -$363.2K
YoY Change 316.65% -267.07%
Net Earnings / Revenue -1113.15%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 27.41M shares 27.41M shares 27.41M shares
Diluted Shares Outstanding 27.41M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $36.08K
YoY Change 68851.72%
Cash & Equivalents $200.0K $36.08K
Short-Term Investments
Other Short-Term Assets $108.8K $109.8K
YoY Change 355.02%
Inventory
Prepaid Expenses $108.8K $109.8K
Receivables
Other Receivables
Total Short-Term Assets $308.8K $145.8K
YoY Change 1175.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $18.29M $18.40M
YoY Change 2301.12%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $18.29M $18.40M
YoY Change 2301.12%
TOTAL ASSETS
Total Short-Term Assets $308.8K $145.8K
Total Long-Term Assets $18.29M $18.40M
Total Assets $18.60M $18.55M
YoY Change 2266.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $983.0K $167.9K
YoY Change 543.77%
Accrued Expenses $99.34K $100.7K
YoY Change -59.12%
Deferred Revenue
YoY Change
Short-Term Debt $539.0K $473.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.114M $853.8K
YoY Change 358.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.114M $853.8K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.114M $853.8K
YoY Change 358.56%
SHAREHOLDERS EQUITY
Retained Earnings -$4.705M -$3.497M
YoY Change 50.18% 29.92%
Common Stock $21.01M $21.01M
YoY Change 540.28% 680.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.48M $17.69M
YoY Change
Total Liabilities & Shareholders Equity $18.60M $18.55M
YoY Change 2266.47%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$475.4K -$363.2K
YoY Change 316.65% -267.07%
Depreciation, Depletion And Amortization $0.00 $14.33K
YoY Change -100.0%
Cash From Operating Activities -$340.0K -$510.9K
YoY Change 229.46% 701.73%
INVESTING ACTIVITIES
Capital Expenditures $18.49K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $94.74K
YoY Change
Cash From Investing Activities $94.74K -$18.49K
YoY Change -145.84% -100.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 288.8K 565.2K
YoY Change 37.97% -118.02%
NET CHANGE
Cash From Operating Activities -340.0K -510.9K
Cash From Investing Activities 94.74K -18.49K
Cash From Financing Activities 288.8K 565.2K
Net Change In Cash 43.60K 35.79K
YoY Change -143.38% 247.81%
FREE CASH FLOW
Cash From Operating Activities -$340.0K -$510.9K
Capital Expenditures $18.49K
Free Cash Flow -$529.4K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
I-ON DIGITAL CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3031328
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001580490
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity File Number
EntityFileNumber
000-54995
CY2023Q4 us-gaap Assets Current
AssetsCurrent
145839 usd
CY2023Q4 us-gaap Assets
Assets
18546766 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
100659 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
473026 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
853808 usd
CY2023Q4 us-gaap Liabilities
Liabilities
853808 usd
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 3
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
99337 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
539005 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2113778 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2113778 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Revenues
Revenues
usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
usd
CY2023Q3 IONI Gain On Exchange Of Intangible Assets
GainOnExchangeOfIntangibleAssets
usd
IONI Gain On Exchange Of Intangible Assets
GainOnExchangeOfIntangibleAssets
usd
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
IONI Accretion Of Debt Discount
AccretionOfDebtDiscount
usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
usd
IONI Gain On Exchange Of Intangible Assets
GainOnExchangeOfIntangibleAssets
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
IONI Proceeds From Issuance Of Preferred Stock And Preference Stock Two
ProceedsFromIssuanceOfPreferredStockAndPreferenceStockTwo
usd
IONI Proceeds From Issuance Of Preferred Stock And Preference Stock One
ProceedsFromIssuanceOfPreferredStockAndPreferenceStockOne
usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Stock Issued1
StockIssued1
usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Address Address Line1
EntityAddressAddressLine1
1244 N. Stone Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60610
dei City Area Code
CityAreaCode
(866)
dei Local Phone Number
LocalPhoneNumber
440-2278
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27410234 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199959 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36075 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
108836 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
109764 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
308795 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18288979 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18400927 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
18288979 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
18400927 usd
CY2024Q3 us-gaap Assets
Assets
18597774 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
492466 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
79589 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27410234 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27410234 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27410234 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27410234 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2741 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2741 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
21010285 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
21010285 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4705463 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3496501 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
16483996 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
17692958 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18597774 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18546766 usd
CY2023Q3 us-gaap Revenues
Revenues
32625 usd
us-gaap Revenues
Revenues
32625 usd
us-gaap Revenues
Revenues
65250 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
27667 usd
us-gaap Cost Of Revenue
CostOfRevenue
21000 usd
us-gaap Cost Of Revenue
CostOfRevenue
48667 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
4958 usd
us-gaap Gross Profit
GrossProfit
11625 usd
us-gaap Gross Profit
GrossProfit
16583 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
142890 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
41830 usd
us-gaap Professional Fees
ProfessionalFees
334469 usd
us-gaap Professional Fees
ProfessionalFees
225590 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
201399 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
77238 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
436739 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
232908 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
344289 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
119068 usd
us-gaap Operating Expenses
OperatingExpenses
771208 usd
us-gaap Operating Expenses
OperatingExpenses
458498 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-344289 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-114110 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-759583 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-441915 usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3795 usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3795 usd
CY2024Q3 IONI Gain On Exchange Of Intangible Assets
GainOnExchangeOfIntangibleAssets
25682 usd
IONI Gain On Exchange Of Intangible Assets
GainOnExchangeOfIntangibleAssets
25682 usd
CY2024Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
160623 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
478856 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-131146 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-449379 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-475435 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-114110 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1208962 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-441915 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-475435 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-114110 usd
us-gaap Net Income Loss
NetIncomeLoss
-1208962 usd
us-gaap Net Income Loss
NetIncomeLoss
-441915 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27410234 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27410234 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27410234 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27410234 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27410234 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27410234 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25596249 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25596249 shares
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
214286 usd
CY2023Q1 IONI Adjustments To Additional Paid In Capital Distribution Amount
AdjustmentsToAdditionalPaidInCapitalDistributionAmount
-250000 usd
CY2023Q1 IONI Stock Issued During Period Issuance Of Preferred Stock
StockIssuedDuringPeriodIssuanceOfPreferredStock
35714 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-179480 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-179480 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
121000 usd
CY2023Q2 IONI Stock Issued During Period Value Issued For Intangible Asset
StockIssuedDuringPeriodValueIssuedForIntangibleAsset
250000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
219500 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-148325 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
262695 usd
CY2023Q3 IONI Stock Issued During Period Of Preferred Stock To Be Issued
StockIssuedDuringPeriodOfPreferredStockToBeIssued
176342 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-114110 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
324927 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
17692958 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-293919 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
17399039 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-439608 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
16959431 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
16959431 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-475435 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-475435 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
16483996 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
16483996 usd
us-gaap Net Income Loss
NetIncomeLoss
-1208962 usd
us-gaap Net Income Loss
NetIncomeLoss
-441915 usd
us-gaap Share Based Compensation
ShareBasedCompensation
121000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48667 usd
IONI Accretion Of Debt Discount
AccretionOfDebtDiscount
65979 usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3795 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-928 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
23916 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1322 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
243021 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
412877 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-32625 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
65250 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-745920 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12107 usd
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
120425 usd
IONI Gain On Exchange Of Intangible Assets
GainOnExchangeOfIntangibleAssets
25682 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
560353 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
94743 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-560353 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
433786 usd
IONI Proceeds From Issuance Of Preferred Stock And Preference Stock Two
ProceedsFromIssuanceOfPreferredStockAndPreferenceStockTwo
176342 usd
IONI Proceeds From Issuance Of Preferred Stock And Preference Stock One
ProceedsFromIssuanceOfPreferredStockAndPreferenceStockOne
35714 usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
250000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
815061 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
152690 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
815061 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
548532 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
163884 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
286 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36075 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
199959 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286 usd
us-gaap Stock Issued1
StockIssued1
250000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zAggQrAkClk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates in the Preparation of Financial Statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. As a result, actual results could materially differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z4NrQWA82Nxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk are cash arising from its normal business activities. The Company has its cash in high credit quality institutions. The Company currently does not provide for or issue extensions of credit to its clients, vendors or employees. If the Company’s board of directors elected to make a change in current policy, management, pursuant to policy and procedure implementation of the same, would establish methodologies for monitoring and assessing corresponding risks, inclusive of the potential for concentrations and the related adequacy of loss reserves going forward.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
550000 shares
us-gaap Net Income Loss
NetIncomeLoss
-1208962 usd
us-gaap Net Income Loss
NetIncomeLoss
-441915 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-475435 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-114110 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27410234 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27410234 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25596249 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25596249 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27410234 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27410234 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27410234 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27410234 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
9780 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
5705 usd
CY2024Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
815 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
0 usd
CY2023Q4 us-gaap Payments To Employees
PaymentsToEmployees
100000 usd
CY2024Q2 us-gaap Payments To Suppliers
PaymentsToSuppliers
2699 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
108836 usd
CY2023Q4 IONI Other Nonoperating Impairment Loss
OtherNonoperatingImpairmentLoss
-8199 usd
CY2023 IONI Asset Value
AssetValue
327501 usd
CY2024Q3 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
116630 usd
CY2024Q3 IONI Cost Price
CostPrice
90948 usd
IONI Gain On Exchange Of Intangible Assets
GainOnExchangeOfIntangibleAssets
25682 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
236553 usd
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
120425 usd
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
3795 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18288979 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130500 usd
us-gaap Revenues
Revenues
32625 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
550000 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
1 pure
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
65979 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
76974 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
10995 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
539005 usd
us-gaap Interest Expense
InterestExpense
478856 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
492466 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19724220 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
71342 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
176342 usd
CY2023Q4 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
Each share of Series C Preferred Stock is convertible into twenty (20) shares of Common Stock and is entitled to twenty (20) votes per share
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27410234 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27410234 shares
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-044625-index-headers.html Edgar Link pending
0001493152-24-044625-index.html Edgar Link pending
0001493152-24-044625.txt Edgar Link pending
0001493152-24-044625-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ioni-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
ioni-20240930_cal.xml Edgar Link unprocessable
ioni-20240930_pre.xml Edgar Link unprocessable
ioni-20240930_lab.xml Edgar Link unprocessable
ioni-20240930_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending